Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 08 2019
Historique:
received: 04 01 2019
accepted: 23 07 2019
entrez: 10 8 2019
pubmed: 10 8 2019
medline: 8 1 2020
Statut: epublish

Résumé

Molecular chaperones such as Hsp40 and Hsp70 hold the androgen receptor (AR) in an inactive conformation. They are released in the presence of androgens, enabling transactivation and causing the receptor to become aggregation-prone. Here we show that these molecular chaperones recognize a region of the AR N-terminal domain (NTD), including a FQNLF motif, that interacts with the AR ligand-binding domain (LBD) upon activation. This suggests that competition between molecular chaperones and the LBD for the FQNLF motif regulates AR activation. We also show that, while the free NTD oligomerizes, binding to Hsp70 increases its solubility. Stabilizing the NTD-Hsp70 interaction with small molecules reduces AR aggregation and promotes its degradation in cellular and mouse models of the neuromuscular disorder spinal bulbar muscular atrophy. These results help resolve the mechanisms by which molecular chaperones regulate the balance between AR aggregation, activation and quality control.

Identifiants

pubmed: 31395886
doi: 10.1038/s41467-019-11594-y
pii: 10.1038/s41467-019-11594-y
pmc: PMC6687723
doi:

Substances chimiques

AR protein, human 0
Androgens 0
DNAJA2 protein, human 0
HSP40 Heat-Shock Proteins 0
HSP70 Heat-Shock Proteins 0
HSPA1A protein, human 0
Ligands 0
Protein Aggregates 0
Receptors, Androgen 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3562

Subventions

Organisme : European Research Council
ID : 648201
Pays : International
Organisme : NINDS NIH HHS
ID : R01 NS059690
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007863
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS055746
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM064337
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007315
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Annu Rev Pathol. 2019 Jan 24;14:1-27
pubmed: 30089230
Structure. 2018 Jan 2;26(1):145-152.e3
pubmed: 29225078
Exp Biol Med (Maywood). 2014 Nov;239(11):1405-13
pubmed: 24990484
J Biol Chem. 2004 Jul 16;279(29):30643-53
pubmed: 15107424
Biophys J. 2016 Jun 7;110(11):2361-2366
pubmed: 27276254
Nat Rev Mol Cell Biol. 2013 Oct;14(10):630-42
pubmed: 24026055
Elife. 2014 May 27;3:e02218
pubmed: 24867638
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
Exp Biol Med (Maywood). 2003 Feb;228(2):111-33
pubmed: 12563018
J Clin Oncol. 2002 Jul 1;20(13):3001-15
pubmed: 12089231
Cell. 2018 Jul 26;174(3):758-769.e9
pubmed: 30033370
Nat Rev Urol. 2015 Jan;12(1):26-36
pubmed: 25512207
Nature. 1991 Jul 4;352(6330):77-9
pubmed: 2062380
Cancer Res. 2018 Jul 15;78(14):4022-4035
pubmed: 29764864
J Am Chem Soc. 2010 Jul 28;132(29):9948-51
pubmed: 20604554
J Mol Biol. 2012 Aug 24;421(4-5):466-90
pubmed: 22306404
Cell Chem Biol. 2016 Aug 18;23(8):992-1001
pubmed: 27499529
J Neurochem. 2008 Feb;104(3):846-58
pubmed: 17986219
Nat Methods. 2006 Dec;3(12):995-1000
pubmed: 17072308
Science. 1995 Jun 2;268(5215):1303-4
pubmed: 7761850
Endocr Rev. 2004 Apr;25(2):276-308
pubmed: 15082523
J Biol Chem. 2000 Jul 28;275(30):22986-94
pubmed: 10816582
Cell Rep. 2015 Dec 15;13(10):2312-23
pubmed: 26673324
Cell. 2014 Jun 19;157(7):1685-97
pubmed: 24949977
J Neurosci. 2004 May 19;24(20):4778-86
pubmed: 15152038
Hum Mol Genet. 1999 May;8(5):731-41
pubmed: 10196362
Cell Mol Life Sci. 2005 Mar;62(6):670-84
pubmed: 15770419
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4758-63
pubmed: 15037741
Science. 1985 Aug 30;229(4716):834-8
pubmed: 4023714
Mol Biosyst. 2012 Sep;8(9):2323-33
pubmed: 22732719
Neuron. 2002 Aug 29;35(5):843-54
pubmed: 12372280
Annu Rev Biochem. 2013;82:323-55
pubmed: 23746257
Neuron. 2002 Aug 29;35(5):855-64
pubmed: 12372281
J Mol Biol. 2015 Apr 10;427(7):1575-88
pubmed: 25683596
Mol Cell. 2017 Sep 21;67(6):947-961.e5
pubmed: 28890336
Methods Enzymol. 2001;339:377-89
pubmed: 11462822
J Biol Chem. 2018 Jul 6;293(27):10796-10809
pubmed: 29764935
Elife. 2017 Aug 10;6:
pubmed: 28826504
Nat Struct Mol Biol. 2009 Dec;16(12):1279-85
pubmed: 19915590
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
J Clin Invest. 2006 Oct;116(10):2663-72
pubmed: 16981011
Biochemistry. 2008 Mar 18;47(11):3360-9
pubmed: 18284208
Proteins. 2001 Jan 1;42(1):38-48
pubmed: 11093259
PLoS Biol. 2014 Nov 18;12(11):e1001998
pubmed: 25406061
J Med Chem. 2018 Jul 26;61(14):6163-6177
pubmed: 29953808
EMBO J. 2001 Mar 1;20(5):1042-50
pubmed: 11230128
J Mol Biol. 2012 Feb 3;415(5):881-99
pubmed: 22178474
J Biol Chem. 2002 Dec 27;277(52):50855-9
pubmed: 12388541
J Mol Biol. 2011 Aug 19;411(3):614-32
pubmed: 21708173
Nat Commun. 2019 May 2;10(1):2034
pubmed: 31048691
J Biol Chem. 2000 Aug 25;275(34):26164-71
pubmed: 10840043
Chem Rev. 2004 Aug;104(8):3607-22
pubmed: 15303830
Mol Cancer Ther. 2019 Jan;18(1):39-50
pubmed: 30297360
Handb Clin Neurol. 2018;148:625-632
pubmed: 29478604
Annu Rev Pharmacol Toxicol. 2015;55:353-71
pubmed: 25292434
EMBO J. 1997 Apr 1;16(7):1501-7
pubmed: 9130695
J Biol Chem. 2015 Jan 30;290(5):2560-76
pubmed: 25505179
Nat Commun. 2018 Nov 16;9(1):4700
pubmed: 30446660
J Biol Chem. 2018 Feb 16;293(7):2370-2380
pubmed: 29255093
Cancer Lett. 2006 Jan 8;231(1):12-9
pubmed: 16356826
Mol Cell Endocrinol. 2013 Apr 30;369(1-2):52-62
pubmed: 23395916
Ann Neurol. 1998 Aug;44(2):249-54
pubmed: 9708548
Nat Chem Biol. 2013 Feb;9(2):112-8
pubmed: 23222885
Cell. 2014 Feb 27;156(5):963-74
pubmed: 24581495
Endocr Rev. 1997 Jun;18(3):306-60
pubmed: 9183567
Am J Pathol. 2006 Jan;168(1):195-204
pubmed: 16400023
ACS Chem Biol. 2016 Sep 16;11(9):2499-505
pubmed: 27356095
Mol Cell. 2004 Nov 5;16(3):425-38
pubmed: 15525515
Science. 1994 Feb 18;263(5149):971-3
pubmed: 8310296

Auteurs

Bahareh Eftekharzadeh (B)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Varuna C Banduseela (VC)

Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.

Giulio Chiesa (G)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Paula Martínez-Cristóbal (P)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Jennifer N Rauch (JN)

University of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.

Samir R Nath (SR)

Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.

Daniel M C Schwarz (DMC)

University of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.

Hao Shao (H)

University of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.

Marta Marin-Argany (M)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Claudio Di Sanza (C)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Elisa Giorgetti (E)

Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.

Zhigang Yu (Z)

Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.

Roberta Pierattelli (R)

CERM and Department of Chemistry "Ugo Schiff", University of Florence, Via Luigi Sacconi 6, 50019, Sesto Fiorentino, Florence, Italy.

Isabella C Felli (IC)

CERM and Department of Chemistry "Ugo Schiff", University of Florence, Via Luigi Sacconi 6, 50019, Sesto Fiorentino, Florence, Italy.

Isabelle Brun-Heath (I)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Jesús García (J)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.

Ángel R Nebreda (ÁR)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
ICREA, Passeig Lluís Companys 23, 08010, Barcelona, Spain.

Jason E Gestwicki (JE)

University of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA. jason.gestwicki@ucsf.edu.

Andrew P Lieberman (AP)

Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA. liebermn@umich.edu.

Xavier Salvatella (X)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. xavier.salvatella@irbbarcelona.org.
Joint BSC-IRB Research Programme in Computational Biology, Baldiri Reixac 10, 08028, Barcelona, Spain. xavier.salvatella@irbbarcelona.org.
ICREA, Passeig Lluís Companys 23, 08010, Barcelona, Spain. xavier.salvatella@irbbarcelona.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH